Our Students

I obtained a Bachelor’s degree in Biochemistry with a Year in Industry at the University of Leeds. During this time, I spent a year working in the Investigative Toxicology group at UCB BIoPharma in Belgium exploring novel biomarkers of drug-induced kidney injury for toxicity assessments. I then completed my undergraduate thesis project in the lab of Alan Berry working on structural studies to uncover the crystal structure of IdmH, a putative polyketide cyclase and an enzymatic component of the NRPS/PKS system which generates the antibiotic indanomycin.

I completed a MSci in Genetics at University College London. I then spent two and a half years working as a research technician in Dr Filipe Cabreiro’s microbiology-metabolism lab, exploring the three-way host-microbiome-environment relationship, using a C. elegans model.

I completed my undergraduate degree in Molecular and Cellular Biology at the University of Bath. During my degree, I undertook a placement year to research novel autophagy adaptor proteins in redox homeostasis under Professor Luo at the Peninsula Schools of Medicine and Dentistry. When I returned to Bath for my final year, I joined Professor Tosh’s lab where I was involved in the characterization of novel transcription factors associated with transdifferentiation events that occur in Barrett’s Oesophagus disease.

I completed my undergraduate degree in Molecular Medicine and a master’s degree in Biochemistry and Biophysics at the Albrecht Ludwig University of Freiburg.

I completed my undergraduate and master’s degree in Pharmaceutical Biotechnology at the University of Milan (Italy). During my BSc I examined the molecular mechanisms of stress in the development of depression (University of Milan). During my MSc my work focused on the crystallisation of a Dengue virus protein for drug discovery purposes (internship at University College London). After graduating, I enrolled in the ORISE post-bac fellowship program at the National Institutes of Health (USA) where I worked on a basic cell biology project, looking at the interplay between structure and function of the endoplasmic reticulum.

I completed my undergraduate degree in Developmental Biology at the University of Manchester, where I developed an interest in the role of physical cues in regulating cell fate. I then spent a year working as a publishing assistant at the Nature Publishing Group. Finally, I studied for an MPhil in Biological Sciences at the University of Cambridge, during which I further pursued my interest in the cellular interactions that occur in response to injury using a mouse model that allows for lineage tracing of a specific pulmonary mesenchymal cell type.

I obtained my Bachelor’s degree in Biology at The University of Bristol, gaining research experience in a range of areas, including trypanosome parasites in Prof Wendy Gibson’s lab and type 1 diabetes in Prof Kathleen Gillespie’s lab. After briefly considering a career in nutritional sciences, I chose to pursue my interest in autoimmune diseases by undertaking a Master’s in immunology at King’s College London. During my MSc, I worked in Prof Leonie Taams’s lab, investigating IL-17-producing cell types in spondylarthritis. Following my MSc, I took up a research assistant position in Dr Sophie Papa’s lab, investigating T cell exhaustion in patients with non-small cell lung cancer, through the use of CyTOF.

I completed my MEng in Biomedical Engineering at Queen Mary, University of London with my thesis in the lab of Prof Julien Gautrot. I then spent 3 years working in medical device development within the Medical Physics department at the RVI in Newcastle. Here I was awarded an ICURe grant from Innovate UK to act as an entrepreneurial lead on a project to develop a new technology to improve organ transplantation outcomes.

I obtained a Bachelor's Degree in Biochemistry at Imperial College London. During this time I worked in the lab of Professor Andrea Crisanti, developing genetic engineering techniques for population control of A. gambiae mosquitoes. I further completed an MSc in Neuroscience at Imperial, where I worked with Professor Nicholas Mazarakis on the development of a gene therapy for CDKL5 Deficiency Disorder. My project involved differentiation of astrocytes from patient-derived iPSCs.

I completed my undergraduate degree in Biotechnology Engineering at Tecnológico de Monterrey in Mexico, and after graduating I worked as a Voluntary Research Intern in the Varela Lab at the Institute of Neurobiology of the National Autonomous University of Mexico (UNAM). I was awarded a scholarship from the Mexican Council of Science and Technology to pursue a master's degree in Neuroscience in Developmental Neurobiology at King's College London (2020-21).

I obtained my bachelor’s degree in Neuroscience from University College Dublin, Ireland. During this time, I undertook a Wellcome Trust-funded project at UCD in the area of Alzheimer’s Disease, as well as an Erasmus placement at Cambridge University modelling Pelizaeus-Merzbacher disease with iPSCs, in the lab of Prof David Rowitch. Following my studies, I became a research assistant at the National Institute for Cellular Biotechnology at Dublin City University. Here, I developed organotypic models of uveal melanoma from primary patient tumours during a post of 18-months. Following this, I moved to London where I took up a research assistant position at KCL, exploring the role of molecular chaperones in iPSC-derived astrocytes in the context of Alzheimer's Disease.

I completed my undergraduate degree in Human Anatomy at the University of Dundee and moved to London in 2019 to obtain my masters in Neuroscience at King’s College London. While completing my MSc I developed a special interest in harnessing the potential of organoids for studying neurodevelopment, and during my thesis developing an open-source high content analysis pipeline to analyse hiPSC-derived gastruloids. Before starting my PhD, I was fortunate enough to experience research out with my niche in the lab of Sibylle Mittnacht at the UCL Cancer Institute, contributing to work on identifying therapeutic vulnerability of RB-1 mutant osteosarcoma to Parp1,2 inhibitors.